Up-regulation of glutamate concentration in the putamen and in the prefrontal cortex of asymptomatic SIVmac251-infected macaques without major brain involvement

Journal of Neurochemistry

Volumn 88, Issue 4, 2004, Pages 928-938

  Bossuet, Christophe ^a   Vaufrey, Françoise ^b   Condé, Françoise ^b   Chrétien, Fabrice ^a,d   Pichon, Jacques ^c   Hantraye, Philippe ^b   Le Grand, Roger ^a   Dormont, Dominique ^a   Gras, Gabriel ^a,e  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^c UNIVERSITÉ D'ORLÉANS   (France)

^d FACULTÉ DE MÉDECINE   (France)

^e INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

High performance liquid chromatography; Immunohistochemistry; Magnetic resonance spectroscopy; Pathogenesis; Primate; Simian immunodeficiency virus

Indexed keywords

4 AMINOBUTYRIC ACID; ACETIC ACID; ALANINE; ASPARTIC ACID; CD68 ANTIGEN, HUMAN; CHOLINE; CREATINE; DIFFERENTIATION ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; LEUKOCYTE ANTIGEN; N ACETYLASPARTIC ACID; PROTEIN; TAURINE; VALINE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; GLIOSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACACA; MALE; METABOLISM; METHODOLOGY; MONKEY DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PLASMA; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TIME; UPREGULATION; VIROLOGY; VIRUS LOAD; VIRUS STRAIN;

ANIMALIA; MACACA; PRIMATES; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 1042289648     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02237.x     Document Type: Article

References (91)

1. Barker P. B., Soher B. J., Blackband S. J., Chatham J. C., Mathews V. P. and Bryan R. N. (1993) Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed. 6, 89-94.
2. Barker P. B., Lee R. R. and McArthur J. C. (1995) AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 195, 58-64.
3. Berghom K. A., Bonnett J. H. and Hoffman G. E. (1994) cFos immunoreactivity is enhanced with biotin amplification. J. Histochem. Cytochem. 42, 1635-1642.
4. Bidlingmeyer B. A., Cohen S. A. and Tarvin T. L. (1984) Rapid analysis of amino acids using pre-column derivatization. J. Chromatogr. 336, 93-104.
5. Brand A., Richter-Landsberg C. and Leibfritz D. (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev. Neurosci. 15, 289-298.
6. Budka H., Wiley C. A., Kleihues P. et al. (1991) HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1, 143-152.
7. Chang L., Ernst T., Poland R. E. and Jenden D. J. (1996) In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci. 58, 2049-2056.
8. Chang L., Ernst T., Witt M. D., Ames N., Gaiefsky M. and Miller E. (2002) Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage 17, 1638-1648.
9. Chao C. C. and Hu S. (1994) Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16, 172-179.
10. Chao C. C., Hu S., Tsang M., Weatherbee J., Molitor T. W., Anderson W. R. and Peterson P. K. (1992) Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. J. Clin. Invest. 90, 1786-1793.
11. Chong W. K., Sweeney B., Wilkinson I. D. et al. (1993) Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 188, 119-124.
12. Chong W. K., Paley M., Wilkinson I. D., Hall-Craggs M. A., Sweeney B., Harrison M. J., Miller R. F. and Kendall B. E. (1994) Localized cerebral proton MR spectroscopy in HIV infection and AIDS. Am. J. Neuroradiol. 15, 21-25.
13. Chrétien F., Vallat-Decouvelaere A. V., Bossuet C., Rimaniol A. C., Le Grand R., Le Pavec G., Creminon C., Dormont D., Gray F. and Gras G. (2002) Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaques. Neuropathol. Appl. Neurobiol. 28, 410-417.
14. Dautry C., Vaufrey F., Brouillet E., Bizat N., Henry P. G., Conde F., Bloch G. and Hantraye P. (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J. Cereb. Blood Flow Metab. 20, 789-799.
15. De Stefano N., Matthews P. M. and Arnold D. L. (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn. Reson. Med. 34, 721-727.
16. Desrosiers R. C. (1990) The simian immunodeficiency viruses. Annu. Rev. Immunol. 8, 557-578.
17. Dreyer E. B. and Lipton S. A. (1995) The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J. Neurosci. 7, 2502-2507.
18. Ebisu T., Rooney W. D., Graham S. H., Weiner M. W. and Maudsley A. A. (1994) N-Acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging. J. Cereb. Blood Flow Metab. 14, 373-382.
19. Ellis C. M., Lemmens G., Williams S. C., Simmons A., Dawson J., Leigh P. N. and Chaudhuri K. R. (1997) Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopatreated Parkinson's disease: a proton magnetic resonance spectroscopy study. Neurology 49, 438-444.
20. Ernst T., Itti E., Itti L. and Chang L. (2000) Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: a coregistered (1)H MRS and SPECT study. J. Magn. Reson. Imaging 12, 859-865.
21. Espey M. G., Ellis R. J., Heaton R. K. and Basile A. S. (1999) Relevance of glutamate levels in the CSF of patients with HIV-1-associated dementia complex. Neurology 53, 1144-1145.
22. Everall I. P., Luthert P. J. and Lantos P. L. (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337, 1119-1121.
23. Everall I., Luthert P. and Lantos P. (1993) A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J. Neuropathol. Exp. Neurol. 52, 561-566.
24. Fatkenheuer G., Theisen A., Rockstroh J. et al. (1997) Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. Aids 11, F113-F116.
25. Ferrarese C., Aliprandi A., Tremolizzo L., Stanzani L., De Micheli A., Dolara A. and Frattola L. (2001) Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57, 671-675.
26. Fine S. M., Angel R. A., Perry S. W., Epstein L. G., Rothstein J. D., Dewhurst S. and Gelbard H. A. (1996) Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J. Biol. Chem. 271, 15303-15306.
27. Gonzalez R. G., Cheng L. L., Westmoreland S. V., Sakaie K. E., Becerra L. R., Lee P. L., Masliah E. and Lackner A. A. (2000) Early brain injury in the SIV-macaque model of AIDS. Aids 14, 2841-2849.
28. Gras G., Chrétien F., Vallat-Decouvelaere A. V. et al. (2003) Regulated expression of sodium-dependent glutamate transporters and glutamine synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol. 13, 211-222.
29. Gray F., Haug H., Chimelli L., Geny C., Gaston A., Scaravilli F. and Budka H. (1991) Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy. Acta Neuropathol. 82, 229-233.
30. Gray F., Adle-Biassette H., Levy Y., Wingertsmann L., Hery C. and Tardieu M. (1996) Neuronal apoptosis in the course of human immunodeficiency virus infection. Bull. Acad. Natl Med. 180, 1855-1867.
31. Gray F., Adle-Biassette H., Chretien F., Lorin de la Grandmaison G., Force G. and Keohane C. (2001) Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin. Neuropathol. 20, 146-155.
32. Higuchi T., Graham S. H., Fernandez E. J., Rooney W. D., Gaspary H. L., Weiner M. W. and Maudsley A. A. (1997) Effects of severe global ischemia on N-acetylaspartate and other metabolites in the rat brain. Magn. Reson. Med. 37, 851-857.
33. Holshouser B. A., Komu M., Moller H. E. et al. (1995) Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magn. Reson. Med. 33, 589-594.
34. Hsu S. M., Raine L. and Fanger H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
35. Hu S., Sheng W. S., Ehrlich L. C., Peterson P. K. and Chao C. C. (2000) Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7, 153-159.
36. Hurtrel B., Chakrabarti L., Hurtrel M., Maire M. A., Dormont D. and Montagnier L. (1991) Early SIV encephalopathy. J. Med. Primatol. 20, 159-166.
37. Jarvik J. G., Lenkinski R. E., Grossman R. I., Gomori J. M., Schnall M. D. and Frank I. (1993) Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 186, 739-744.
38. Kalra S., Cashman N. R., Genge A. and Arnold D. L. (1998) Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9, 1757-1761.
39. Kaul M., Garden G. A. and Lipton S. A. (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994.
40. Kerr S. J., Armati P. J., Guillemin G. J. and Brew B. J. (1998) Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. Aids 12, 355-363.
41. Ketzler S., Weis S., Haug H. and Budka H. (1990) Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. 80, 92-94.
42. Kondo K., Hashimoto H., Kitanaka J., Sawada M., Suzumura A., Marunouchi T. and Baba A. (1995) Expression of glutamate transporters in cultured glial cells. Neurosci. Lett. 188, 140-142.
43. Kort J. J. (1998) Impairment of excitatory amino acid transport in astroglial cells infected with the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 14, 1329-1339.
44. Laubenberger J., Haussinger D., Bayer S., Thielemann S., Schneider B., Mundinger A., Hennig J. and Langer M. (1996) HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 199, 805-810.
45. Lipton S. A. (1992) Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport 3, 913-915.
46. Lipton S. A. (1994) HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists. Mol. Neurobiol. 8, 181-196.
47. Lipton S., Sucher N., Kaiser P. and Dreyer E. (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7, 111-118.
48. Lopez-Villegas D., Lenkinski R. E. and Frank I. (1997) Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc. Natl Acad. Sci. USA 94, 9854-9859.
49. Magnuson D. S. K., Knudsen B. E., Geiger J. D., Brownstone R. M. and Nath A. (1995) Human immunodeficiency virus type 1 Tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37, 373-380.
50. Masliah E., Achim C. L., Ge N., DeTeresa R., Terry R. D. and Wiley C. A. (1992a) Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32, 321-329.
51. Masliah E., Ge N., Morey M., DeTeresa R., Terry R. D. and Wiley C. A. (1992b) Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest. 66, 285-291.
52. McArthur J. C., Becker P. S., Parisi J. E., Trapp B., Selnes O. A., Comblath D. R., Balakrishnan J., Griffin J. W. and Price D. (1989) Neuropathological changes in early HIV-1 dementia. Ann. Neurol. 26, 681-684.
53. Menon D. K., Baudouin C. J., Tomlinson D. and Hoyle C. (1990) Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J. Comput. Assist. Tomogr. 14, 882-885.
54. Menon D. K., Ainsworth J. G., Cox I. J., Coker R. C., Sargentoni J., Coutts G. A., Baudouin C. J., Kocsis A. E. and Harris J. R. (1992) Proton MR spectroscopy of the brain in AIDS dementia complex. J. Comput. Assist. Tomogr 16, 538-542.
55. Meyerhoff D. J., MacKay S., Bachman L., Poole N., Dillon W. P., Weiner M. W. and Fein G. (1993) Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 43, 509-515.
56. Meyerhoff D. J., MacKay S., Poole N., Dillon W. P., Weiner M. W. and Fein G. (1994) N-Acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals. Magn. Reson. Imaging 12, 653-659.
57. Nakajima K., Tohyama Y., Kohsaka S. and Kurihara T. (2001) Ability of rat microglia to uptake extracellular glutamate. Neurosci. Lett. 307, 171-174.
58. Nath A., Haughey N. J., Jones M., Anderson C., Bell J. E. and Geiger J. D. (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 47, 186-194.
59. Navia B. A., Jordan B. D. and Price R. W. (1986) The AIDS dementia complex. I. Clinical features. Ann. Neurol. 19, 517-524.
60. Neildez O., Le Grand R., Cheret A., Caufour P., Vaslin B., Matheux F., Theodoro F., Roques P. and Dormont D. (1998) Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIVmac251. Res. Virol. 149, 53-68.
61. Noda M., Nakanishi H. and Akaike N. (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92, 1465-1474.
62. Pfefferbaum A., Adalsteinsson E., Spielman D., Sullivan E. V. and Lim K. O. (1999) In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn. Reson. Med. 41, 276-284.
63. Piani D., Frei K., Do K. Q., Cuenod M. and Fontana A. (1991) Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133, 159-162.
64. Piani D., Spranger M., Frei K., Schaffner A. and Fontana A. (1992) Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 22, 2429-2436.
65. Price R. W., Sidtis J. J. and Brew B. J. (1991) AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol. 1, 155-162.
66. Rimaniol A. C., Haik S., Martin M., Le Grand R., Boussin F. D., Dereuddre-Bosquet N., Gras G. and Dormont D. (2000) Na+-dependent high-affinity glutamate transport in macrophages. J. Immunol. 164, 5430-5438.
67. Rimaniol A. C., Mialocq P., Clayette P., Dormont D. and Gras G. (2001) Role of glutamate transporters in the regulation of glutathione levels in human macrophages. Am. J. Physiol. Cell Physiol. 281, C1964-C1970.
68. Ringler D. J., Hunt R. D., Desrosiers R. C., Daniel M. D., Chalifoux L. V. and King N. W. (1988) Simian immunodeficiency virus induced meningoencephalitis: natural history and retrospective study. Ann. Neurol. 23, S101-S107.
69. Rothstein J. D., Jin L., Dykes-Hoberg M. and Kuncl R. W. (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl Acad. Sci. USA 90, 6591-6595.
70. Sacktor N. (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J. Neurovirol. 8, 115-121.
71. Sacktor N. C., Lyles R. H., Skolasky R. L., Kleeberger C., Selnes O. A., Miller E. N., Becker J. T., Cohen B., McArthur J. C. and The multicenter AIDS cohort study (1999) HIV-1-related neurological disease incidence changes in the era of highly active antiretroviral therapy. Neurology 52, A252-A253.
72. Spencer D. C. and Price R. W. (1992) Human immunodeficiency virus and the central nervous system. Annu. Rev. Microbiol. 46, 655-693.
73. Tarasow E., Wiercinska-Drapalo A., Kubas B., Dzienis W., Orzechowska-Bobkiewicz A., Prokopowicz D. and Walecki J. (2003) Cerebral MR spectroscopy in neurologically asymptomatic HIV-infected patients. Acta Radiol. 44, 206-212.
74. Ten Haaft P., Verstrepen B., Uberla K., Rosenwirth B. and Heeney J. (1998) A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J. Virol. 72, 10281-10285.
75. Thiebot H., Louache F., Vaslin B., de Revel T., Neildez O., Larghero J., Vainchenker W., Dormont D. and Le Grand R. (2001) Early and persistent bone marrow hematopoiesis defect in simian/human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection. J. Virol. 75, 11594-11602.
76. Tracey I., Carr C. A., Guimaraes A. R., Worth J. L., Navia B. A. and Gonzalez R. G. (1996) Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 46, 783-788.
77. Tracey I., Lane J., Chang I., Navia B., Lackner A. and Gonzalez R. G. (1997) 1H magnetic resonance spectroscopy reveals neuronal injury in a simian immunodeficiency virus macaque model. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15, 21-27.
78. Tyor W. R., Glass J. D., Griffin J. W., Becker P. S., McArthur J. C., Bezman L. and Griffin D. E. (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31, 349-360.
79. Urenjak J., Williams S. R., Gadian D. G. and Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989.
80. Vallat-Decouvelaere A. V., Chrétien F., Gras G., Le Pavec G., Dormont D. and Gray F. (2003) Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A neuroprotective role for activated microglia? J. Neuropathol Exp Neurol. 62, 475-485.
81. Vermathen P., Ende G., Laxer K. D., Knowlton R. C., Matson G. B. and Weiner M. W. (1997) Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Ann. Neurol. 42, 194-199.
82. Vesce S., Bezzi P., Rossi D., Meldolesi J. and Volterra A. (1997) HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett. 411, 107-109.
83. Vion-Dury J., Nicoli F., Salvan A. M., Confort-Gouny S., Dhiver C. and Cozzone P. J. (1995) Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345, 60-61.
84. Volterra A., Trotti D. and Racagni G. (1994) Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. Mol. Pharmacol. 46, 986-992.
85. Westmoreland S. V., Halpern E. and Lackner A. A. (1998) Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. J. Neurovirol. 4, 260-268.
86. Wiley C. A. and Achim C. (1994) Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol. 36, 673-676.
87. Wiley C. A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L. and Terry R. (1991) Neocortical damage during HIV infection. Ann. Neurol. 29, 651-657.
88. Wiley C. A., Soontornniyomkij V., Radhakrishnan L., Masliah E., Mellors J., Hermann S. A., Dailey P. and Achim C. L. (1998) Distribution of brain HIV load in AIDS. Brain Pathol. 8, 277-284.
89. Williams K. C., Corey S., Westmoreland S. V., Pauley D., Knight H., deBakker C., Alvarez X. and Lackner A. A. (2001) Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 193, 905-915.
90. Zink M. C., Amedee A. M., Mankowski J. L., Craig L., Didier P., Carter D. L., Munoz A., Murphey-Corb M. and Clements J. E. (1997) Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am. J. Pathol. 151, 793-803.
91. Zink M. C., Spelman J. P., Robinson R. B. and Clements J. E. (1998) SIV infection of macaques - modeling the progression to AIDS dementia. J. Neurovirol. 4, 249-259.